<DOC>
	<DOCNO>NCT01443520</DOCNO>
	<brief_summary>Tramadol opioid analgesic , widely use treatment acute neuropathic pain . After oral administration , tramadol rapidly almost completely absorbed . Tramadol extensively metabolise O- N-demethylation , catalyse liver CYP-450 enzyme . O-desmethyltramadol active metabolite formation catalyse CYP2D6 . This study aim investigate possible interaction oral tramadol duloxetine venlafaxine . Duloxetine known inhibit CYP2D6 . Twelve healthy male female adult non-smoking volunteer age 18-40 year body weight within ±15 % ideal weight height take study . Primary endpoint study plasma concentration tramadol metabolite .</brief_summary>
	<brief_title>Effect Duloxetine Venlafaxine Pharmacokinetics Pharmacodynamics Oral Tramadol : A Three-phase Randomized Balanced Cross-over Study Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Healthy volunteer Age 1840 Body weight within ±15 % ideal weight height A previous history intolerance study drug related compound additives Concomitant drug therapy kind least 14 day prior study Existing recent significant disease History hematological , endocrine , metabolic gastrointestinal disease , include gut motility disorder History asthma kind drug allergy Previous present alcoholism , drug abuse , psychological emotional problem likely invalidate inform consent , limit ability subject comply protocol requirement A positive test result urine toxicology A `` yes '' answer one Abuse Questions Pregnancy nurse Donation blood 4 week prior study Special diet life style condition would compromise condition study interpretation result Participation study involve investigational market drug product concomitantly within one month prior entry study Smoking one month start study whole study period Any history coagulation abnormality , also first degree relative</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>